Evidence map›Paper›PMID 29637889›Full record

SynthesisEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2018

The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.

Christina Greenaway, Manish Pareek, Claire-Nour Abou Chakra, Moneeza Walji, Iuliia Makarenko, Balqis Alabdulkarim, Catherine Hogan, Ted McConnell, Brittany Scarfo, Robin Christensen and 8 more

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Open flanks in the management of tuberculosis in Germany under the pressure of migration.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Christina GreenawayDivision of Infectious Diseases, Jewish General Hospital, McGill University, Montreal, Canada.
Manish PareekDepartment of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
Claire-Nour Abou ChakraDivision of Infectious Diseases, Sherbrooke, Canada.
Moneeza WaljiCentre for Clinical Epidemiology of the Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
Iuliia MakarenkoCentre for Clinical Epidemiology of the Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
Balqis AlabdulkarimCentre for Clinical Epidemiology of the Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
Catherine HoganDivision of Infectious Diseases, Jewish General Hospital, McGill University, Montreal, Canada.
Ted McConnellCentre for Clinical Epidemiology of the Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
Brittany ScarfoCentre for Clinical Epidemiology of the Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
Robin ChristensenMusculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
Anh TranNational Health and Medical Research Council, NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
Nick RowbothamNational Health and Medical Research Council, NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
Marieke J van der WerfEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Teymur NooriEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Kevin PottieBruyere Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Alberto MatteelliClinic of Infectious and Tropical Diseases, University of Brescia and Brescia Spedali Civili General Hospital, World Health Organization Collaborating Centre for TB/HIV and TB Elimination, Brescia, Italy.
Dominik ZennerRespiratory Diseases Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, United Kingdom.
Rachael L MortonNational Health and Medical Research Council, NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.

Funding

Department of Health PDF-2015-08-102
6 · The paper itself

Abstract

BackgroundMigrants account for a large and growing proportion of tuberculosis (TB) cases in low-incidence countries in the European Union/European Economic Area (EU/EEA) which are primarily due to reactivation of latent TB infection (LTBI). Addressing LTBI among migrants will be critical to achieve TB elimination.

Indexed as

Antitubercular AgentsCost-Benefit AnalysisEmigrants and ImmigrantsHealth Care CostsHumansInterferon-gamma Release TestsLatent TuberculosisMass ScreeningTransients and MigrantsTuberculin TestTuberculosisAntitubercular AgentsEU/EEAlatent TBmigrantscreeningtuberculosis

Identifiers

PMID29637889
PMCPMC5894253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.